SEC Form 4 research
| Issuer | Cue Biopharma, Inc. |
|---|---|
| Tickers | CUE |
| Reporting owners | 36 |
| Officers and directors | 11 |
| Last public filing | 2026-10-15 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-14 | 2026-10-12 | Ray Sumita | S | 1,844 | $28.05 | Not reported |
| 2026-10-14 | 2026-10-12 | Meluzio Michael Vincent | S | 1,144 | $28.05 | Not reported |
| 2026-10-14 | 2026-10-12 | Lin Shao-Lee | S | 1,087 | $28.05 | Not reported |
| 2026-10-14 | 2026-10-12 | Lin Shao-Lee | S | 10,000 | $27.5 | Not reported |
| 2026-08-28 | 2026-07-09 | Sarraf Pasha | A | 18,400 | $0 | Not reported |
| 2026-08-28 | 2026-07-09 | Garzone Pamela | A | 18,900 | $0 | Not reported |
| 2026-08-17 | 2026-08-13 | Meluzio Michael Vincent | S | 3 | $31.13 | Not reported |
| 2026-08-17 | 2026-08-13 | Meluzio Michael Vincent | S | 4,106 | $30.35 | Not reported |
| 2026-08-17 | 2026-08-13 | Meluzio Michael Vincent | S | 1,519 | $29.37 | Not reported |
| 2026-08-17 | 2026-08-13 | Ray Sumita | S | 4 | $31.13 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.